GL1X · GenesisL1 explorer

Research workbench

Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications

Analyse Design of an insulin analog with enhanced receptor-binding selectivity.… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FQ9
Type
protein
Length
102 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.35
Molecule
Insulin
UniProt
P01308
Ligands
ZN

Structure

x-ray diffraction · resolution 1.35 · 2 distinct chains · 55% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CInsulinprotein2167% helix, 10% strandP01308
B, DInsulinprotein3047% helix, 13% strandP01308

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

5 interfaces between chains.

  • C–D · 925 Ų buried · 13 hydrogen bonds · protein-protein
  • A–B · 917 Ų buried · 14 hydrogen bonds · protein-protein
  • B–D · 616 Ų buried · 6 hydrogen bonds · protein-protein
  • A–D · 65 Ų buried · 0 hydrogen bonds · protein-protein
  • B–C · 50 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 d-amino, 2 modified (disulfide, D-amino acid, nonstandard).

Compared structures

  • 3FQ9 · Design of an insulin analog with enhanced receptor-binding selectivity. rationale… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.